Sabine Vogler,Nina Zimmermann,Zaheer-Ud-Din Babar
Sabine Vogler
Background: In recent years, high-cost medicines have increasingly been challenging the public health budget in all countries including high-income economies. In this context, this study aims to survey, analyze and compar...
Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry [0.03%]
影响制药行业建筑设计模式转变的宏观经济因素
Raphaela Marie Louisa Dierks,Olivier Bruyère,Jean-Yves Reginster et al.
Raphaela Marie Louisa Dierks et al.
Technological innovations, new regulations, increasing costs of drug productions and new demands are only few key drivers of a projected alternation in the pharmaceutical industry. The purpose of this review is to understand the macro econo...
The impact of chronic conditions on the economic burden of cancer survivorship: a systematic review [0.03%]
慢性病对癌症幸存者经济负担的影响：系统评价研究
Sun Hee Rim,Gery P Guy Jr,K Robin Yabroff et al.
Sun Hee Rim et al.
This systematic review examines the excess cost of chronic conditions on the economic burden of cancer survivorship among adults in the US. Areas covered: Twelve published studies were identified. Although studies varied substantially in po...
Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review [0.03%]
晚期乳腺癌各线治疗的健康状态效用值：系统综述
Noman Paracha,Per-Olof Thuresson,Santiago G Moreno et al.
Noman Paracha et al.
For patients with late-stage (metastatic) breast cancer, the impact of treatment on health-related quality of life is a key factor in decision-making. A systematic review was conducted to identify health state utility values (HSUVs) for lat...
Systematic review and overview of health economic evaluation models in obesity prevention and therapy [0.03%]
系统评价和综述肥胖预防与治疗的卫生经济学评估模型
Bjoern Schwander,Mickaël Hiligsmann,Mark Nuijten et al.
Bjoern Schwander et al.
Given the increasing clinical and economic burden of obesity, it is of major importance to identify cost-effective approaches for obesity management. Areas covered: This study aims to systematically review and compile an overview of publish...
The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendations [0.03%]
中东欧定价和报销决策中非经济标准的使用：问题、趋势与建议
Katarzyna Kolasa,Zoltan Kalo,Vladimir Zah
Katarzyna Kolasa
Introduction: According to some experts, there is still room for improvement with regard to the inclusion of ethical considerations in Health Technology Assessment (HTA). ...
Vaccination planning in Italy: increasing vaccines while reducing coverage? [0.03%]
意大利的疫苗接种计划：增加疫苗供应同时降低覆盖范围？
Livio Garattini,Alessandro Curto,Nick Freemantle
Livio Garattini
An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany [0.03%]
在德国开展九价人乳头瘤病毒疫苗全面接种的公共卫生影响和费用效果分析估算
Nathalie Largeron,Karl Ulrich Petry,Jorge Jacob et al.
Nathalie Largeron et al.
Introduction: Since 2007, the German Standing Vaccination Committee recommends HPV vaccination for girls aged 12-17 with a 2- (Cervarix®) or 4-valent (Gardasil®) vaccine. A 9-valent vaccine (Gardasil 9®) recently recei...
Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration [0.03%]
低血糖事件和糖化血红蛋白水平对磺脲类药物减量和停药的影响
Pedro A Laires,Jackson Tang,Chun Po Steve Fan et al.
Pedro A Laires et al.
Background: A retrospective cohort study using GE Centricity electronic medical records assessed the association between post-index hypoglycemia and HbA1c with discontinuation and down-titration of sulfonylureas among pat...
Cost-effectiveness of caspofungin versus liposomal amphotericin B in the treatment of systemic fungal infections: a systematic review of economic analyses [0.03%]
卡泊芬净与脂质包囊两性霉素B治疗全身性真菌感染的成本效益分析：经济分析系统的综述
Sóstenes Mistro,Lorena Rosa,Bárbara Gomes et al.
Sóstenes Mistro et al.
Introduction: The treatment of fungal infections in severely ill patients is a clinical and economic challenge worldwide. Liposomal amphotericin B and caspofungin are highly effective antifungal drugs; however, they are v...